Osteo Bi-Flex Triple Strength Joint Health Supplements, Glucosamine Chondroitin Tablets, 160 Count

We were all Made to Move…and Osteo Bi-Flex Triple Strength helps you stay that way.* Our flagship formula was created to help nurture and protect your joints, while also helping to support joint mobility.* It provides Joint Shield, an exclusive herbal extract that helps with occasional joint stiffness and soothes joints.* Osteo Bi-Flex is a drug-free way to improve joint comfort in just 7 days.* Experience joint health for the long term with Osteo Bi-Flex Triple Strength!*

Osteo Bi-Flex Triple Strength Joint Health Supplements, Glucosamine Chondroitin Tablets, 160 Count Shows Improved Joint Comfort within 7 Days†* #1 Pharmacist recommended brand Osteo Bi-Flex Glucosamine Chondroitin with Joint Shield Coated Tablets help strengthen your joints.* These tablets include Joint Shield, Glucosamine, and Chondroitin. A leading joint health brand with the beneficial Joint Shield 5-Loxin Advanced (100 mg of Boswellia serrata Extract). * or (1) These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.2 or (2) IRI Total US-Multi Outlet Latest 52 weeks ending 05/28/23.1 or ◊ or (3) Based on the results of the U.S Pharmacy Times Survey of Pharmacists’ OTC Recommendations who recommend a “joint health” dietary supplement, 2023-2024.† or (4) Based on three human studies with 5-LOXIN ADVANCED® where subjects rated their joint health over time, subjects’ joint health improved within 7 days, and continued to improve throughout the duration of the studies.Δ or (5) Refers to level of Glucosamine HCl per tablet compared to regular strength.‡ or (7) In a select study, participants taking Joint Shield (5-LOXIN ADVANCED®) or placebo over 90 days rated their joint comfort during daily activities.Individual results may vary.5-LOXIN ADVANCED® is a registered trademark of PLT Health Solutions – Laila Nutraceuticals, LLC. U.S. Patent #8,551,496 and patents pending.